Literature DB >> 9342890

How important are airfreight rates and vaccine packaging in cost-saving efforts for the Expanded Programme on Immunization?

B Schreuder1, H Arentsen, M Matosse.   

Abstract

Vaccines constitute the single most important cost factor in the Expanded Programme on Immunization (EPI) in Mozambique and in view of future new disease-control initiatives, the proportional expenditure on vaccines will only increase. Airfreight may contribute up to at least 25% of the total cost of delivered vaccine. Air transport of vaccine provided by UNICEF was arranged by the vaccine supplier. As a result of a lack of control mechanisms, airfreight rates were unnecessarily high and showed considerable variation. By negotiating rates directly with the airlines, the EPI management team in Mozambique succeeded in reducing them from an average of about US$ 12 per kg to US$ 4 per kg, equivalent to an annual saving of US$ 100,000. Vaccine vials are typically packaged in one of the following types of boxes: small colourful boxes containing 5-10 vials or bigger more functional boxes containing 50-100 vials. The packaging of vials in smaller boxes can double airfreight costs compared with bigger boxes. The EPI management team for Mozambique recommends that UNICEF should take over from suppliers the arrangements for shipping vaccine and negotiate airfreight rates centrally; further, WHO should tighten current vaccine-packaging standards for net packaging volume per dose, so that packaging in uneconomical small boxes can be eliminated.

Mesh:

Substances:

Year:  1997        PMID: 9342890      PMCID: PMC2486971     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  Immunization programs and their costs.

Authors:  L Brenzel; P Claquin
Journal:  Soc Sci Med       Date:  1994-08       Impact factor: 4.634

  1 in total
  2 in total

1.  Single versus multi-dose vaccine vials: an economic computational model.

Authors:  Bruce Y Lee; Bryan A Norman; Tina-Marie Assi; Sheng-I Chen; Rachel R Bailey; Jayant Rajgopal; Shawn T Brown; Ann E Wiringa; Donald S Burke
Journal:  Vaccine       Date:  2010-06-03       Impact factor: 3.641

2.  Aligning new interventions with developing country health systems: target product profiles, presentation, and clinical trial design.

Authors:  Alan Brooks; Julia K Nunes; Andrew Garnett; Robin Biellik; Didier Leboulleux; Ashley J Birkett; Christian Loucq
Journal:  Glob Public Health       Date:  2012-07-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.